Arrowgrass Capital Partners (US)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$610K Sell
12,054
-31,262
-72% -$1.61M 0.16% 51
2019
Q3
$2.04M Buy
43,316
+1,814
+4% +$82.8K 0.15% 130
2019
Q2
$1.96M Buy
41,502
+4,017
+11% +$185K 0.05% 267
2019
Q1
$1.8M Buy
+37,485
New +$1.88M 0.05% 260

Other funds holding CAH

Arrowgrass Capital Partners (US)'s CAH Position: Q4 2019 in Review

Arrowgrass Capital Partners (US) reduced its Cardinal Health (CAH) stake by 72% in Q4 2019, selling an estimated $1.61M and leaving 12,054 shares worth $610K. The position accounts for 0.16% of the portfolio, ranked #51.

Arrowgrass Capital Partners (US) first reported a position in CAH in Q1 2019 and has held it in 4 quarters since. The position peaked at $2.04M in Q3 2019. 714 funds tracked by Wall St. Rank hold CAH as of Q4 2019.

  • Arrowgrass Capital Partners (US) held 12,054 shares of Cardinal Health worth $610K as of Q4 2019.
  • Arrowgrass Capital Partners (US) sold 31,262 Cardinal Health shares in Q4 2019, an estimated $1.61M.
  • Cardinal Health made up 0.16% of Arrowgrass Capital Partners (US)'s portfolio in Q4 2019, its #51 holding.
  • Arrowgrass Capital Partners (US) first reported a position in Cardinal Health in Q1 2019 and has held it in 4 quarters since.
  • Arrowgrass Capital Partners (US)'s Cardinal Health position peaked at $2.04M in Q3 2019.
  • 714 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2019, filed 14 Feb 2020.